Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 6Unknown 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma, Large B-Cell, Diffuse 26Lymphoma 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 11Neuroblastoma 10Lymphoma, Non-Hodgkin 10Central Nervous System Neoplasms 8Lymphoma, Follicular 6Hodgkin Disease 6Sarcoma 5Retinoblastoma 5Lymphoma, T-Cell, Peripheral 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Immunoblastic Lymphadenopathy 4Wilms Tumor 3Oligodendroglioma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Kidney Neoplasms 3Burkitt Lymphoma 3Astrocytoma 3Recurrence 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Plasma Cell 2Neoplasms 2Multiple Myeloma 2Leukemia, T-Cell 2Leukemia, Biphenotypic, Acute 2Enteropathy-Associated T-Cell Lymphoma 2

Interventions

Doxorubicin 2brostallicin 1Vinorelbine 1Vincristine 1Topotecan 1Temozolomide 1Radiotherapy 1Molecular Diagnostic Techniques 1Microarray Analysis 1Ifosfamide 1Etoposide 1Dactinomycin 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Malignant mesenchymal tumor × Vincristine × Clear all
NCT00379457 2013-08-12

Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
600 enrolled
Sarcoma

Malignant mesenchymal tumor, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡